Gonadorelin vs HCG on TRT: Why Clinics Switched and What the Evidence Shows

The Short Answer

Why Gonadorelin Is Offered Instead of HCG

The most likely explanation is regulatory. On March 23, 2020, chorionic gonadotropin moved from a drug approval to a biologics license, along with dozens of other protein products on FDA's transition list. FDA's notice to compounders said those products "will not be eligible for the exemptions for compounded drugs under sections 503A and 503B," and it named human chorionic gonadotropin specifically. From then on, hCG had to come from a licensed manufacturer.

Gonadorelin landed on the other side of the line. FDA's rules treat an amino acid chain as a protein only if it's "greater than 40 amino acids in size." Gonadorelin is a ten-residue peptide, according to its USP monograph, so it's still regulated as an ordinary drug, and pharmacies can still compound it.

Compounders now market it directly for men's hormone therapy. On September 1, 2026, Olympia Pharmaceuticals, which describes itself as an FDA-registered 503B outsourcing facility and 503A pharmacy, announced a ready-to-use 1 mg/mL gonadorelin vial as part of its "men's hormone portfolio."

What you won't find is an FDA-approved gonadorelin product for people. Both human brands are discontinued: Factrel (gonadorelin hydrochloride, NDA 018123, first approved September 30, 1982) and Lutrepulse (gonadorelin acetate, NDA 019687, first approved October 10, 1989). Drugs@FDA lists no marketed gonadorelin product for people, so the gonadorelin a TRT clinic prescribes is compounded and not FDA-approved.

How They Work: LH Mimic vs Pulsed GnRH

Testosterone therapy suppresses the body's own signaling chain. In a 2005 JCEM study, weekly testosterone enanthate drove LH and FSH down to about 5% and 3% of baseline and cut testosterone inside the testes by 94%. Both hCG and gonadorelin try to restore part of that chain, but at different points.

HCG: a stand-in for LH at the testes

The Novarel label says "the action of HCG is virtually identical to that of pituitary LH," stimulating the Leydig cells of the testes to produce androgens. It skips the brain and pituitary entirely. That's why it works even while TRT keeps those upstream signals switched off. The regimens on the Fresenius Kabi hCG label for males are injections two or three times a week.

Gonadorelin: a signal to the pituitary that sustains LH release only when pulsed

Gonadorelin is synthetic GnRH, the hypothalamic hormone that tells the pituitary to release LH and FSH. The USP monograph describes gonadorelin acetate as a synthetic hormone that stimulates release of luteinizing hormone. The catch is timing. In the classic 1978 Science study by Belchetz, Knobil and colleagues, hourly GnRH pulses restored gonadotropin release in monkeys with hypothalamic lesions, while a continuous infusion did not, and switching from pulses to a constant supply desensitized the pituitary.

That's why the best-studied use of gonadorelin to restore sperm production in men relies on pumps. In a 2025 study of men with congenital hypogonadotropic hypogonadism, gonadorelin was given under the skin by a portable infusion pump at a starting dose of 10–15 µg every 90 minutes. Compounded gonadorelin for TRT is sold as injectable vials. Whether a few injections can do what a 90-minute pump does is the open question.

Evidence Quality: Small Studies vs Almost None

HCG on TRT

The evidence is modest but direct:

• Coviello et al., 2005: 29 healthy men on 200 mg testosterone enanthate weekly for three weeks. At 250 IU and 500 IU, hCG every other day kept intratesticular testosterone near or above baseline (7% below and 26% above), versus a 94% drop with placebo; the lowest dose tested, 125 IU, left it 25% below baseline.
• Hsieh et al., 2013: 26 men on testosterone plus 500 IU hCG every other day, followed a mean of 6.2 months. None became azoospermic, and 9 contributed to a pregnancy.

The AUA guideline says clinicians "may use" hCG, along with SERMs or aromatase inhibitors, for men with testosterone deficiency who want to maintain fertility. That's a conditional recommendation backed by Grade C evidence. More detail in HCG alongside TRT.

Gonadorelin

The good gonadorelin data come from a different setting: men born with hypogonadotropic hypogonadism, using pumps, not on TRT.

• A 2021 meta-analysis in the World Journal of Men's Health (7 studies, 420 men) found pulsatile GnRH produced larger testicular volume and sperm about 5.3 months sooner than gonadotropin injections. Rates of sperm appearance, sperm concentration and pregnancy didn't differ significantly. Allergic reactions occurred mostly with GnRH; gynecomastia and acne were more common with gonadotropins. The authors called for high-quality randomized trials.
• The 2025 single-center retrospective cohort of 155 men found similar success rates (82.1% with pulsatile GnRH vs 75.8% with hCG/HMG, not a significant difference), a shorter time to sperm (12.34 vs 14.74 months) and larger final testicular volume (15 vs 12 mL).

Those results show GnRH pulses can wake up the testes in men whose problem is a missing brain signal. They don't show that compounded gonadorelin injections preserve testicular size or sperm in men taking testosterone. We searched for controlled trials of that use and didn't find any. Until one exists, gonadorelin on TRT is an educated guess, while hCG is a small but tested intervention.

FDA Compounding Status as of October 2026

We checked FDA's lists on October 12, 2026:

• Gonadorelin can be compounded. Section 503A allows bulk ingredients that meet a USP monograph or are components of FDA-approved drugs. Gonadorelin acetate has a USP monograph, and FDA's 503B list (updated March 21, 2025) marks it as a component of FDA-approved drugs, in Category 1 "under evaluation."
• It isn't flagged as a safety risk. Gonadorelin isn't on FDA's Category 2 safety-risk list (current as of April 22, 2026) or the withdrawn-for-safety list in 21 CFR 216.24.
• HCG can't be compounded under 503A or 503B. It has to be a licensed product such as Novarel, Pregnyl or Fresenius Kabi's generic chorionic gonadotropin.
• Kisspeptin isn't a workaround. Kisspeptin-10 has been on FDA's Category 2 safety-risk list for 503A compounding since September 29, 2023.

Cost and Access

HCG's cost is easy to see at clinics that price it separately. At TRT Nation, testosterone alone is $99.99/mo and TRT + HCG is $180/mo, a difference of $80.01 a month. Both plans have a 2.5-month minimum purchase, and labs are extra: a $129 lab fee, or submit your own labs up to 6 months old.

TRT Nation doesn't list gonadorelin, and we didn't find published gonadorelin add-on prices that we could verify, so ask any clinic offering it for the monthly cost in writing. Our guide to online TRT with HCG lists which clinics show hCG on their sites.

Which One to Ask Your Prescriber About

This is a prescriber decision, and it depends on what you're trying to protect.

• You're trying to conceive now. The AUA's strong recommendation is that testosterone "should not be prescribed to men who are currently trying to conceive." Neither add-on changes that. Ask about non-TRT approaches instead; see enclomiphene as a fertility-preserving alternative.
• You want to keep the option of kids later. HCG is the add-on with direct, if small, evidence in men on testosterone. Get a baseline semen analysis before you start, and read what TRT does to sperm count.
• Your main concern is testicular size or comfort. Either may be offered. If a clinic proposes gonadorelin, ask how often you'd inject, what evidence supports that schedule, and how they'll judge whether it's working.
• You're switching from hCG to gonadorelin because of cost or supply. Don't make the swap on your own. Ask your prescriber what follow-up they'll use to check that it's doing the job.

The Bottom Line

Gonadorelin is easier for pharmacies to supply, which probably helps explain why it is offered. But availability isn't evidence. HCG acts directly on the testes and has small studies in men on TRT; gonadorelin needs pulsed delivery to work as designed, and its supportive data come from pump therapy in a different group of men.

1. Write down your goal: fertility now, fertility later, or testicular size.
2. Ask your prescriber which add-on fits that goal and what the evidence is.
3. Confirm whether the product is licensed (hCG) or compounded (gonadorelin), who makes it, and the all-in monthly price.
4. For background on hCG itself, see our HCG and TRT guide.